Beximco Pharmaceuticals Ltd
Company Overview
Beximco Pharmaceuticals Ltd. is one of the leading drug manufacturers and exporters in Bangladesh. Based in Dhaka, the company is a part of Beximco Group and playing an active role in the pharmaceuticals industry of the country. The company was founded in 1976 and started its operation in 1980.1 The company started manufacturing its own products under proper licensing in 1980 and prior to that it used to import products from Germany and USA. In 1983 the company launched its own formulation brands and put a step ahead in the journey.
Currently, the company is holding the third position in the pharmaceuticals industry of Bangladesh with an 8.39% market share (based on profit).2
Its major competitors are Square Pharmaceuticals (16% market share), Incepta (10.21% market share), and Opsonin (5.54% market share). Right now, Beximco Pharma employs more than 4,700 people. The company is currently producing 300+ generic medicines. The company’s portfolio includes antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, dermatology, gastrointestinal, and more.
Beximco Pharmaceuticals Ltd. has a presence in more than 80 countries and it has expanded its global consumer base through exporting in some highly regulated markets in the last decade. In 2018-19 fiscal year, the export earnings of Beximco Pharmaceuticals Ltd. amounted to 32.46 million USD - the highest among other companies in the country that year. Moreover, Beximco pharma is the first-ever pharmaceutical company in Bangladesh that has explored the US market in 2016. The company has also introduced the world's first generic remdesivir for Covid-19 treatment in 2020.
Beximco Pharma has made its share market debut in 1985 by getting listed in Dhaka Stock Exchange (DSE). Currently, the company is also listed on Chittagong Stock Exchange (CSE) – second of the two stock exchanges of the country, and Alternative Investment Market (AIM) at London Stock Exchange.
The company has a mission to enhance human health and well-being through providing contemporary and affordable medicines while maintaining global quality standards. Moreover, the company has a vision of becoming th3e most trusted, admired, and successful pharmaceutical company in the region. Beximco is determined to attain this standard through strengthening research and development capabilities and building a strong presence in the global market.
Beximco has achieved several national and international awards for its outstanding contribution to the pharmaceutical industry of Bangladesh. It is the only Company in the region that won the highly prestigious SCRIP Award as the “Best Pharma Company in an Emerging Market”4 and also the Global Generics and Biosimilars Awards 2021 in the category of Company of the Year, Asia Pacific.
